Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05707455
Other study ID # P.T.REC/012/004727
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2022
Est. completion date October 31, 2022

Study information

Verified date September 2023
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aimed to evaluate the hematological factors and iron status in aerobic versus anaerobic training in athletic females.


Description:

In both the short and long term, physical training causes iron status deterioration in sporty females. Nonetheless, little is known about the effect of different forms of exercise (aerobic versus anaerobic) on haematological variables and iron status in sporty females during adolescence. As a result, the purpose of this study was to compare the haematological variables and iron status in aerobic versus anaerobic exercise in adolescent female athletes. Another goal was to compare aerobic and anaerobic groups in terms of iron status classifications, such as normal iron status, iron deficiency with or without anaemia.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date October 31, 2022
Est. primary completion date October 31, 2022
Accepts healthy volunteers
Gender Female
Age group 16 Years to 19 Years
Eligibility Inclusion Criteria: - Healthy, virginal, nonsmoker, female athletes. - Age from 16 to 19 years. - Body mass index < 25 kg/m2. - Having the same socio-economic level. - Following a normal balanced nutrition. Exclusion Criteria: - Using any medical or hormonal therapy that might influence the iron status. - Vegetarian athletes. - Having menorrhagia or amenorrhea. - Chronic inflammatory condition or existing infection. - Diabetic, hypertensive or cardiac athletes. - Haematological disease (with the exception of iron deficiency with or without anaemia). - Having transfusion of blood.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
evaluating blood levels of hemoglobin, hematocrit, red blood cell count, mean corpuscular volume, mean corpuscular hemoglobin concentration, serum transferrin and serum ferritin.
evaluating blood levels of hemoglobin, hematocrit, red blood cell count, mean corpuscular volume, mean corpuscular hemoglobin concentration, serum transferrin and serum ferritin.

Locations

Country Name City State
Egypt Local clubs Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of hemoglobin (Hb) Blood samples were collected between 8:00 and 9:00 a.m. after an overnight fast and time of relaxation. The athletic girls were asked to refrain from exercising the day before sample. Blood was taken from the antecubital vein and placed in one EDTA tube and one beads tube for serum separation. An automatic cell counter (Sysmex XS 1000, Japan) was used to measure hemoglobin (Hb). 2 months
Primary Assessment of hematocrit (Hct) Blood samples were collected between 8:00 and 9:00 a.m. after an overnight fast and time of relaxation. The athletic girls were asked to refrain from exercising the day before sample. Blood was taken from the antecubital vein and placed in one EDTA tube and one beads tube for serum separation. An automatic cell counter (Sysmex XS 1000, Japan) was used to measure hematocrit (Hct). 2 months
Primary Assessment of red blood cell (RBC) count Blood samples were collected between 8:00 and 9:00 a.m. after an overnight fast and time of relaxation. The athletic girls were asked to refrain from exercising the day before sample. Blood was taken from the antecubital vein and placed in one EDTA tube and one beads tube for serum separation. An automatic cell counter (Sysmex XS 1000, Japan) was used to measure red blood cell (RBC) count. 2 months
Primary Assessment of mean corpuscular volume (MCV) Blood samples were collected between 8:00 and 9:00 a.m. after an overnight fast and time of relaxation. The athletic girls were asked to refrain from exercising the day before sample. Blood was taken from the antecubital vein and placed in one EDTA tube and one beads tube for serum separation. An automatic cell counter (Sysmex XS 1000, Japan) was used to measure mean corpuscular volume (MCV). 2 months
Primary Assessment of mean corpuscular hemoglobin concentration (MCHC) Blood samples were collected between 8:00 and 9:00 a.m. after an overnight fast and time of relaxation. The athletic girls were asked to refrain from exercising the day before sample. Blood was taken from the antecubital vein and placed in one EDTA tube and one beads tube for serum separation. An automatic cell counter (Sysmex XS 1000, Japan) was used to measure mean corpuscular hemoglobin concentration (MCHC). 2 months
Primary Assessment of serum transferrin Blood samples were collected between 8:00 and 9:00 a.m. after an overnight fast and time of relaxation. The athletic girls were asked to refrain from exercising the day before sample. Blood was taken from the antecubital vein and placed in one EDTA tube and one beads tube for serum separation. The serum sample was centrifuged, and the serum transferrin was measured using COBAS Integra 400 plus, Switzerland. 2 months
Primary Assessment of serum ferritin Blood samples were collected between 8:00 and 9:00 a.m. after an overnight fast and time of relaxation. The athletic girls were asked to refrain from exercising the day before sample. Blood was taken from the antecubital vein and placed in one EDTA tube and one beads tube for serum separation. The serum sample was centrifuged, and the serum ferritin was measured using ADVIA Centaur XPT, Germany. 2 months
Secondary Anthropometric measures A weight-height scale was used to assess the weight (Kg) and height (m) for each female athlete in the two groups. The body mass index (BMI) was then calculated by dividing the weight by the height squared (Kg/m2). 2 months
Secondary Assessment of participation age to sport Each female athlete was asked about her age of participation to sport to assess her training profile. 2 months
Secondary Assessment of number of hours of training per week Each female athlete was asked about the number of hours of training per week to assess her training profile. 2 months
Secondary Assessment of training experience The training experience in years was calculated by subtracting the female athlete's age of participation to training from her chronological age. 2 months
See also
  Status Clinical Trial Phase
Completed NCT02996786 - Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational Runners N/A